152 related articles for article (PubMed ID: 8821629)
1. Epstein-Barr virus-induced human B-cell lymphoma arising in HuPBL-SCID chimeric mice: characterization and the role of CD40 stimulation in their treatment and prevention.
Funakoshi S; Beckwith M; Fanslow W; Longo DL; Murphy WJ
Pathobiology; 1995; 63(3):133-42. PubMed ID: 8821629
[TBL] [Abstract][Full Text] [Related]
2. Antibodies to CD40 prevent Epstein-Barr virus-mediated human B-cell lymphomagenesis in severe combined immune deficient mice given human peripheral blood lymphocytes.
Murphy WJ; Funakoshi S; Beckwith M; Rushing SE; Conley DK; Armitage RJ; Fanslow WC; Rager HC; Taub DD; Ruscetti FW
Blood; 1995 Sep; 86(5):1946-53. PubMed ID: 7544649
[TBL] [Abstract][Full Text] [Related]
3. Effects of CD40 stimulation in the prevention of human EBV-lymphomagenesis.
Funakoshi S; Taub DD; Asai O; Hirano A; Ruscetti FW; Longo DL; Murphy WJ
Leuk Lymphoma; 1997 Jan; 24(3-4):187-99. PubMed ID: 9156649
[TBL] [Abstract][Full Text] [Related]
4. [Molecular pathological characteristics of human B-cell lymphomas induced by Epstein-Barr virus].
Gan RL; Yin ZH; Liu TF; Dong BH; Zhou JG; Yao KT
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Oct; 35(10):925-9. PubMed ID: 14515211
[TBL] [Abstract][Full Text] [Related]
5. CD40 stimulation promotes human secondary immunoglobulin responses in HuPBL-SCID chimeras.
Murphy WJ; Funakoshi S; Fanslow WC; Rager HC; Taub DD; Longo DL
Clin Immunol; 1999 Jan; 90(1):22-7. PubMed ID: 9884349
[TBL] [Abstract][Full Text] [Related]
6. Human-derived IgG level as an indicator for EBV-associated lymphoma model in Hu-PBL/SCID chimeras.
Tang Y; He R; Zhang Y; Liu F; Cheng A; Wu Y; Gan R
Virol J; 2011 May; 8():213. PubMed ID: 21554672
[TBL] [Abstract][Full Text] [Related]
7. Construction of hu-PBL/SCID chimeras and development of EBV-related lymphomas.
Gan RL; Lan K; Yin ZH; Wang LJ; Song Y; Yao KT
Chin Med Sci J; 2005 Mar; 20(1):16-22. PubMed ID: 15844306
[TBL] [Abstract][Full Text] [Related]
8. Study on the role of G1 cyclins in Epstein-Barr virus-associated human lymphomas maintained in severe combined immune deficiency (SCID) mice.
Murai Y; Dobashi Y; Okada E; Ishizawa S; Shiota M; Mori S; Takano Y
Int J Cancer; 2001 Apr; 92(2):232-9. PubMed ID: 11291051
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity among Epstein-Barr virus-seropositive donors in the generation of immunoblastic B-cell lymphomas in SCID mice receiving human peripheral blood leukocyte grafts.
Picchio GR; Kobayashi R; Kirven M; Baird SM; Kipps TJ; Mosier DE
Cancer Res; 1992 May; 52(9):2468-77. PubMed ID: 1314693
[TBL] [Abstract][Full Text] [Related]
10. Identification of IgH gene rearrangement and immunophenotype in an animal model of Epstein-Barr virus-associated lymphomas.
Zhang Y; Peng X; Tang Y; Gan X; Wang C; Xie L; Xie X; Gan R; Wu Y
J Med Virol; 2016 Oct; 88(10):1804-13. PubMed ID: 26991077
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus-induced human B-cell lymphomas in SCID mice reconstituted with human peripheral blood leukocytes.
Mosier DE; Picchio GR; Baird SM; Kobayashi R; Kipps TJ
Cancer Res; 1992 Oct; 52(19 Suppl):5552s-5553s. PubMed ID: 1327510
[TBL] [Abstract][Full Text] [Related]
12. Differential in vitro and in vivo antitumor effects mediated by anti-CD40 and anti-CD20 monoclonal antibodies against human B-cell lymphomas.
Funakoshi S; Longo DL; Murphy WJ
J Immunother Emphasis Tumor Immunol; 1996 Mar; 19(2):93-101. PubMed ID: 8732692
[TBL] [Abstract][Full Text] [Related]
13. Cyclosporine A effectively inhibits graft-versus-host disease during development of Epstein-Barr virus-infected human B cell lymphoma in SCID mouse.
Gan R; Yin Z; Liu T; Wang L; Tang Y; Song Y
Cancer Sci; 2003 Sep; 94(9):796-801. PubMed ID: 12967478
[TBL] [Abstract][Full Text] [Related]
14. Expression of LMP and EBNA genes in Epstein-Barr virus-associated lymphomas in Hu-PBL/SCID mice.
Tang Y; Lu S; Gan X; Liu F; Zhang Y; Luo C; Pan Y; Hong L; Gan R
Oncol Rep; 2016 Feb; 35(2):905-11. PubMed ID: 26548532
[TBL] [Abstract][Full Text] [Related]
15. LMP1-deficient Epstein-Barr virus mutant requires T cells for lymphomagenesis.
Ma SD; Xu X; Plowshay J; Ranheim EA; Burlingham WJ; Jensen JL; Asimakopoulos F; Tang W; Gulley ML; Cesarman E; Gumperz JE; Kenney SC
J Clin Invest; 2015 Jan; 125(1):304-15. PubMed ID: 25485679
[TBL] [Abstract][Full Text] [Related]
16. EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors.
White RE; Rämer PC; Naresh KN; Meixlsperger S; Pinaud L; Rooney C; Savoldo B; Coutinho R; Bödör C; Gribben J; Ibrahim HA; Bower M; Nourse JP; Gandhi MK; Middeldorp J; Cader FZ; Murray P; Münz C; Allday MJ
J Clin Invest; 2012 Apr; 122(4):1487-502. PubMed ID: 22406538
[TBL] [Abstract][Full Text] [Related]
17. Human B-cell lymphoma in severe combined immunodeficient mice after active infection with Epstein-Barr virus.
Boyle TJ; Tamburini M; Berend KR; Kizilbash AM; Borowitz MJ; Lyerly HK
Surgery; 1992 Aug; 112(2):378-86. PubMed ID: 1322566
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: implications for the pathogenesis of EBV-positive lymphomas in man.
Rowe M; Young LS; Crocker J; Stokes H; Henderson S; Rickinson AB
J Exp Med; 1991 Jan; 173(1):147-58. PubMed ID: 1845872
[TBL] [Abstract][Full Text] [Related]
19. Gene analysis of Epstein-Barr virus-associated lymphomas in Hu-Pbl/SCID chimeras.
Gan R; Xie X; He J; Liu X; Hong L; Tang Y; Liu F; Xie H
Tumori; 2010; 96(3):465-72. PubMed ID: 20845810
[TBL] [Abstract][Full Text] [Related]
20. Adoptive transfer of cytotoxic T lymphocytes for the treatment of transplant-associated lymphoma.
Boyle TJ; Berend KR; DiMaio JM; Coles RE; Via DF; Lyerly HK
Surgery; 1993 Aug; 114(2):218-25; discussion 226. PubMed ID: 8393595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
